Novavax publishes positive efficacy data for its COVID-19 vaccine
Novavax publishes phase 3 trial data from UK study showing positive efficacy results for its COVID-19 vaccine vaccine shown to be 89.3% effective in preventing coronavirus in participants, as well as efficacy against new UK variant UK has secured 60 … read more

